Physician profile
David G Greer
NPI 1013064815
$66,785.41
in general payments reported to CMS, 2019-2025
88 companies · $6,693 in 2025
The $6,693 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $13K · 2021: $11K · 2022: $7,869 · 2023: $11K · 2024: $6,904 · 2025: $6,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,312 · Travel and Lodging: $1,593 · Consulting Fee: $175 · Education: $10.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,772.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,312.00 |
| Travel and Lodging | $1,592.89 |
| Consulting Fee | $175.00 |
| Education | $10.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $12,811.72 | 2019-2024 | Inbrija, Ampyra |
| Livanova USA, INC. | $6,764.25 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Mdd US Operations, LLC | $3,735.14 | 2019-2025 | Gocovri, Gocovri, Qelbree |
| Ucb, INC. | $3,571.03 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Abbvie INC. | $3,282.40 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $2,495.62 | 2019-2025 | |
| Biogen, INC. | $2,279.67 | 2019-2025 | Tysabri, Vumerity, Avonex |
| Csl Behring | $2,248.52 | 2019-2025 | Hizentra |
| Pfizer INC. | $1,729.63 | 2019-2025 | |
| Boston Scientific Corporation | $1,498.80 | 2019-2023 | |
| Neurocrine Biosciences, INC. | $1,331.28 | 2019-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $1,244.73 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,151.18 | 2019-2025 | Austedo Xr, Austedo Xr |
| Alexion Pharmaceuticals, INC. | $1,144.03 | 2019-2025 | Ultomiris, Soliris |
| Emd Serono, INC. | $1,128.59 | 2019-2025 | Mavenclad |
Show all 88 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,033.72 | 2019-2025 | Uplizna, Aimovig |
| Lilly USA, LLC | $1,018.92 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Acadia Pharmaceuticals INC | $1,015.97 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $902.42 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Harmony Biosciences LLC | $735.37 | 2021-2025 | Wakix |
| Supernus Pharmaceuticals, INC. | $730.61 | 2019-2023 | |
| Avanir Pharmaceuticals, INC. | $707.34 | 2019-2022 | |
| Celgene Corporation | $694.92 | 2021-2025 | Zeposia |
| Allergan, INC. | $651.90 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $648.65 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $610.84 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $600.69 | 2022-2025 | Rexulti, Nuedexta |
| Adamas Pharmaceuticals, INC. | $599.87 | 2019-2021 | |
| Lundbeck LLC | $567.49 | 2019-2025 | Rexulti, Vyepti |
| Grifols USA, LLC | $565.52 | 2019-2025 | Gamunex-C |
| Catalyst Pharmaceuticals, INC. | $555.89 | 2019-2025 | Fycompa, Firdapse |
| Eisai INC. | $524.69 | 2019-2024 | |
| Greenwich Biosciences, INC. | $508.37 | 2019-2021 | |
| Kyowa Kirin, INC. | $495.29 | 2019-2024 | Nourianz |
| Medtronic, INC. | $488.27 | 2022-2025 | Percept PC Brainsense |
| Genzyme Corporation | $442.89 | 2019-2025 | |
| Merz Pharmaceuticals, LLC | $416.68 | 2021-2025 | Xeomin, Inbrija, Ampyra |
| Janssen Pharmaceuticals, INC | $399.47 | 2021-2023 | Ponvory |
| Ipsen Biopharmaceuticals, INC | $326.01 | 2021-2025 | Dysport |
| Neurelis, INC. | $315.24 | 2020-2023 | Valtoco |
| Amneal Pharmaceuticals LLC | $314.96 | 2019-2025 | Rytary, Crexont |
| Genentech USA, INC. | $314.60 | 2019-2024 | Ocrevus |
| Arbor Pharmaceuticals, INC. | $289.66 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $287.97 | 2021 | |
| Impel Pharmaceuticals INC. | $281.90 | 2022-2023 | Trudhesa |
| Biohaven Pharmaceutical Holding Company LTD. | $266.74 | 2022 | |
| Sumitomo Pharma America, INC. | $223.51 | 2023-2024 | Aptiom |
| Cycle Pharmaceuticals INC | $217.87 | 2024-2025 | Bafiertam, Tascenso Odt |
| Horizon Therapeutics Plc | $204.62 | 2021-2023 | Uplizna |
| Axsome Therapeutics, INC. | $164.54 | 2023-2025 | Symbravo, Sunosi |
| Upsher-Smith Laboratories LLC | $148.95 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $139.65 | 2021 | |
| Merck Sharp & Dohme LLC | $137.73 | 2021-2023 | Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $135.96 | 2023-2024 | Hyqvia, Gammagard |
| Scilex Pharmaceuticals INC. | $133.23 | 2021-2025 | Ztlido |
| Impel Pharmaceuticals LLC | $130.86 | 2025 | Trudhesa |
| Tg Therapeutics, INC. | $128.83 | 2023-2024 | |
| Currax Pharmaceuticals LLC | $101.10 | 2021-2024 | Onzetra Xsail, Contrave |
| Akcea Therapeutics, INC. | $100.56 | 2019-2021 | |
| Banner Life Sciences, LLC | $96.72 | 2022-2024 | |
| Merz North America, INC. | $89.65 | 2020 | |
| Janssen Biotech, INC. | $87.51 | 2025 | |
| Aucta Pharmaceuticals, INC. | $84.12 | 2024-2025 | Motpoly Xr |
| Ani Pharmaceuticals, INC. | $74.57 | 2022-2025 | Purified Cortrophin Gel |
| Avion Pharmaceuticals | $72.53 | 2022 | |
| C2n Diagnostics, LLC | $64.74 | 2025 | Precivityad2 |
| Abbott Laboratories | $47.41 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $44.07 | 2022-2023 | Quviviq |
| Corium, LLC | $41.92 | 2023 | Adlarity |
| Almatica Pharma LLC | $41.40 | 2021 | |
| Assertio Therapeutics, INC. | $40.64 | 2019 | |
| Zyla Life Sciences, INC. | $34.45 | 2019 | |
| Mallinckrodt Hospital Products INC. | $25.34 | 2020-2022 | |
| Immedica Pharma US, INC. | $23.45 | 2023 | |
| Mirum Pharmaceuticals, INC. | $22.05 | 2024 | Cholbam |
| Promius Pharma LLC | $19.98 | 2019 | |
| Cala Health, INC. | $19.05 | 2023 | Cala Trio |
| Azurity Pharmaceuticals, INC. | $18.66 | 2023 | Horizant |
| Ge Healthcare | $18.04 | 2021 | |
| Alnylam Pharmaceuticals INC. | $16.96 | 2025 | Amvuttra |
| Collegium Pharmaceutical, INC. | $16.16 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.67 | 2024 | Caplyta |
| Grt US Holding, INC. | $14.15 | 2022 | |
| Tanabe Pharma America, INC. | $14.07 | 2022 | |
| Biodelivery Sciences International, INC. | $11.92 | 2020 | |
| Adlon Therapeutics L.P. | $11.91 | 2020 | |
| Sobi, INC | $11.88 | 2021 | |
| Edw Pharma, INC. | $9.53 | 2019 |
Drugs and devices associated with these payments
Vns Therapy Sentiva Model 1000 Generator $3,402Hizentra $1,266Nurtec Odt $1,140Zavzpret $1,030Kesimpta $929Qulipta $900Botox $879Ubrelvy $844Tysabri $689Vumerity $659Ultomiris $613Gocovri $611Wakix $589Ingrezza $583Rexulti $529Briviact $524Vyvgart $504Inbrija $452Percept PC Brainsense $437Nuplazid $434Panzyga $412Epidiolex $407Zeposia $403Octagam Immune Globulin (Human) $390Rystiggo $386Xeomin $334Austedo Xr $332Vyvgart Hytrulo $319Fycompa $303Kisunla $262Avonex $258Trudhesa $239Emgality $234Aptiom $224Paxlovid $219Bafiertam $217Gamunex-C $209Comirnaty $202Vyalev $191Duopa $182Nourianz $180Mavenclad $169Nuedexta $166Amyvid $165Nayzilam $156Tascenso Odt $150Ampyra $149Ongentys $146Mayzent $145Leqembi $132Briumvi $129Uplizna $128Ocrevus $115Fintepla $105Vyepti $102Firdapse $88.19Symbravo $87.94Motpoly Xr $84.12Ztlido $83.56Dysport $77.82Hyqvia $77.54Sunosi $76.60Precivityad2 $64.74Rytary $58.10Skyclarys $54.90Soliris $46.47Onzetra Xsail $45.73Zilbrysq $44.52Adlarity $41.92Aimovig $41.23Purified Cortrophin Gel $37.58Agamree $35.40Plegridy $32.23Quviviq $28.55Nexviazyme $24.64Ztalmy $23.45Belsomra $23.12Cholbam $22.05Aduhelm $21.50Spinraza $20.35Gammagard $20.32Qelbree $19.98Cala Trio $19.05Horizant $18.66Valtoco $18.66Ponvory $17.17Amvuttra $16.96Elyxyb - Celecoxib $16.93Caplyta $15.67Contrave $14.86Crexont $14.04
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.